Physician profile
Amanda Powers
NPI 1770140204
$5,799.77
in general payments reported to CMS, 2019-2025
16 companies · $742 in 2025
The $742 reported for 2025 was more than what 84% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $202 · 2022: $341 · 2023: $3,568 · 2024: $946 · 2025: $742.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,719 · Travel and Lodging: $2,408 · Education: $130.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,718.93 |
| Travel and Lodging | $2,407.75 |
| Education | $130.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $2,292.23 | 2023-2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Medtronic, INC. | $1,545.49 | 2021-2025 | Micra, Linq II, Aurora Ev-Icd Mri Surescan |
| E.R. Squibb & Sons, L.L.C. | $478.84 | 2021-2025 | Camzyos, Eliquis |
| Abiomed | $309.48 | 2024-2025 | Impella |
| Pfizer INC. | $304.09 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $236.08 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $158.77 | 2022-2024 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $149.61 | 2022-2025 | Wainua |
| Boston Scientific Corporation | $115.90 | 2024 | Watchman Access System |
| Merck Sharp & Dohme LLC | $92.59 | 2021-2024 | Verquvo |
| Bayer Healthcare Pharmaceuticals INC. | $28.39 | 2024 | |
| Angiodynamics, INC. | $21.10 | 2024 | Angiovac |
| Regeneron Healthcare Solutions, INC. | $18.51 | 2022 | |
| Amgen INC. | $17.13 | 2024 | Repatha |
| Lexicon Pharmaceuticals, INC. | $16.80 | 2024 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $14.76 | 2024 | Inspire |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Powers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.